nevena damjanov, md, discusses how new agents for advanced hcc will be integrated into the treatment
Published 7 years ago • 118 plays • Length 1:47
Download video MP4
Download video MP3
Similar videos
-
0:55
nevena damjanov, md, discusses new agents being studied for treatment of advanced hcc
-
1:01
nevena damjanov, md, explains how checkpoint inhibitors will be incorporated into the treatment
-
1:13
nevena damianov, md interprets how new advanced hcc agents will integrate into hcc treatment
-
0:43
nevena damjanov, md, on combining cabozantinib with checkpoint inhibitors in advanced hcc patients
-
1:16
nevena damjanov, md, discusses current treatment options and sequencing tkis in hcc
-
0:47
nevena damjanov, md, discusses identifying subgroups of patients for targeted therapies in hcc
-
0:37
nevena damjanov, md, on whether regorafenib will be integrated into clinical practice
-
1:02
nevena damjanov, md, shares the latest news in systemic therapy for advanced hcc at asco 2018
-
10:15
what tumors eat -- and how to poison them | dr. christal sohl | tedxtulsacc
-
6:14
interventional radiology procedures for treatment | chinese
-
17:52
surgery for advanced gastric cancer - definition, staging, surgical principles, d2 lymphadenectomy
-
0:49
nevena damjanov, md, regarding the impact of the redos study in hcc
-
0:34
nevena damjanov, md, shares thoughts on the role of systemic therapy in hcc
-
0:26
nevena damjanov, md, elaborates on the role of tkis in managing 2nd line hcc patients
-
1:00
nevena damianov, md illustrates the promising classes and products for advanced, unresectable hcc
-
0:49
nevena damianov, md on the reasoning for studying pd-l1 inhibition in advanced hcc
-
0:35
nevena damjanov, md, elaborates on stereotactic body radiation therapy in early stage hcc
-
0:46
nevena damjanov, md, outlines the role of tace with systemic therapy in hcc patients
-
0:35
nevena damjanov, md, on the use of pembrolizumab in hcc patients previously treated with sorafenib
-
0:54
nevena damjanov, md, regarding sequencing tkis in hepatocellular carcinoma (hcc)
-
1:14
nevena damjanov, md, on the phase 3 checkpoint 459 trial studying nivolumab in hcc
-
0:32
nevena damjanov, md, shares personal opinion of treatment of patient with a high expression of afp
Clip.africa.com - Privacy-policy